aHR	Adjusted hazard ratio
ACE2	Angiotensin-converting enzyme 2
ADP	Adenosine diphosphate
ARDS	Acute respiratory distress syndrome
CAR-T	Chimeric antigen receptor T cells
CD8	Cluster of differentiation 8
CCL2	Chemokine (C-C motif) ligand 2
CCR3 C-C	chemokine receptor type 3
COVID-19	Coronavirus disease 2019
CRS	Cytokine release syndrome
CSS	Cytokine storm syndrome
CVST	Cerebral venous sinus thrombosis
CSFs	Colony-stimulating factors
GM-CSF	Granulocyte-macrophage colony-stimulating factor
G-CSF	Granulocyte colony-stimulating factor
FDA	Food and Drug Administration
FcγRIIa	Fragment crystallizable gamma region II alpha
FcεRI	Fragment crystallizable epsilon region I
FcεRII	Fragment crystallizable epsilon region II
HLH/MAS	Hemophagocytic lymphohistiocytosis/ macrophage activation syndrome
HIV	Human immunodeficiency virus
HIT	Heparin-induced thrombocytopenia
HITT	Heparin-induced thrombocytopenia with thrombosis
IFNs	Interferons
ILs	Interleukins
KD	Kawasaki disease
MAS	Macrophage activation syndrome
MERS	Middle East Respiratory Syndrome
MCP-1	Monocyte chemoattractant protein-1
M-CSF	Macrophage colony-stimulating factor
MINOCA	Myocardial infarction with non-obstructive coronary arteries
PAF	Platelet activating factor
PEG	Polyethylene glycol
RECOVERY	Randomized Evaluation of COVID-19 therapy
mRNA	Messenger ribonucleic acid
SARS-CoV-2	Severe acute respiratory syndrome coronavirus 2
SARS-COV	Severe acute respiratory syndrome coronavirus
SPC	Special product characteristics
STEMI ST	Segment-elevation myocardial infarction
TNFs	Tumor necrosis factors
TLR TXA	Toll-like receptor Thromboxane